GSK plc
GLAXF · OTC
10/28/2025 | 9/30/2025 | 6/30/2025 | 3/31/2025 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $3,296,000 | $3,599,000 | $4,464,000 |
| Short-Term Investments | – | $10,000 | $20,000 | $21,000 |
| Receivables | – | $7,937,000 | $7,321,000 | $7,059,000 |
| Inventory | – | $6,118,000 | $6,072,000 | $6,000,000 |
| Other Curr. Assets | – | $481,000 | $661,000 | $541,000 |
| Total Curr. Assets | – | $17,842,000 | $17,673,000 | $18,085,000 |
| Property Plant & Equip (Net) | – | $10,132,000 | $9,918,000 | $9,971,000 |
| Goodwill | – | $7,117,000 | $6,734,000 | $6,926,000 |
| Intangibles | – | $16,865,000 | $15,376,000 | $16,258,000 |
| Long-Term Investments | – | $1,083,000 | $0 | $1,011,000 |
| Tax Assets | – | $6,168,000 | $6,581,000 | $6,410,000 |
| Other NC Assets | – | $2,132,000 | $2,976,000 | $2,044,000 |
| Total NC Assets | – | $43,497,000 | $41,585,000 | $42,620,000 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $61,339,000 | $59,258,000 | $60,705,000 |
| Liabilities | – | – | – | – |
| Payables | – | $15,675,000 | $14,820,000 | $15,149,000 |
| Short-Term Debt | – | $2,856,000 | $0 | $1,958,000 |
| Tax Payable | – | $324,000 | $581,000 | $628,000 |
| Deferred Revenue | – | $0 | $0 | $0 |
| Other Curr. Liab. | – | $2,479,000 | $4,977,000 | $3,096,000 |
| Total Curr. Liab. | – | $21,334,000 | $20,378,000 | $20,831,000 |
| LT Debt | – | $14,894,000 | $0 | $0 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $390,000 | $384,000 | $404,000 |
| Other NC Liab. | – | $8,969,000 | $24,142,000 | $25,816,000 |
| Total NC Liab. | – | $24,253,000 | $24,526,000 | $26,220,000 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $0 | $0 | $0 |
| Total Liabilities | – | $45,587,000 | $44,904,000 | $47,051,000 |
| Equity | – | – | – | – |
| Pref Stock | – | $0 | $0 | $0 |
| Common Stock | – | $1,349,000 | $1,349,000 | $1,349,000 |
| Retained Earnings | – | $10,016,000 | $8,797,000 | $8,307,000 |
| AOCI | – | $1,297,000 | $0 | $0 |
| Other Equity | – | $3,486,000 | $4,645,000 | $4,501,000 |
| Total Equity | – | $16,148,000 | $14,791,000 | $14,157,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | -$396,000 | -$437,000 | -$503,000 |
| Total Liab. & Tot. Equity | – | $61,339,000 | $59,258,000 | $60,705,000 |
| Net Debt | $0 | $14,454,000 | -$3,599,000 | -$2,506,000 |